These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4356456)

  • 81. The effects of retinoids on the replication of herpes simplex virus type 1.
    Taylor JL; O'Brien WJ
    Curr Eye Res; 1984 Mar; 3(3):481-8. PubMed ID: 6321106
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antiviral activity of a pyrazino-pyrazine derivative.
    Verini MA; Fioretti A; Casazza AM; Sanfilippo A; Palamidessi G; Ghione M
    Chemotherapy; 1975; 21(3-4):221-30. PubMed ID: 169110
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
    AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Effect of desoxyribonuclease on herpes simplex virus].
    Kossak NI
    Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
    [No Abstract]   [Full Text] [Related]  

  • 85. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Suppression of herpes simplex virus infection by antimitotic substances in the rabbit cornea.
    Tokumaru T; Avitabile A
    Proc Soc Exp Biol Med; 1971 May; 137(1):29-34. PubMed ID: 4325776
    [No Abstract]   [Full Text] [Related]  

  • 89. Antiviral drugs today.
    Goldwater PN
    N Z Med J; 1984 Dec; 97(769):852-4. PubMed ID: 6392956
    [No Abstract]   [Full Text] [Related]  

  • 90. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antiviral drug sensitivity in ocular herpes simplex virus infection.
    Menage MJ; de Clercq E; van Lierde A; Easty VS; Darville JM; Cook SD; Easty DL
    Br J Ophthalmol; 1990 Sep; 74(9):532-5. PubMed ID: 2168202
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD; Nesburn AB
    Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model.
    Harris SR; Boyd MR
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():91-8. PubMed ID: 193825
    [No Abstract]   [Full Text] [Related]  

  • 95. Oral and topical treatment of experimental herpes simplex iritis with bromovinyldeoxyuridine.
    Maudgal PC; Uyttebroeck W; De Clercq E; Missotten L
    Arch Ophthalmol; 1982 Aug; 100(8):1337-40. PubMed ID: 6808980
    [No Abstract]   [Full Text] [Related]  

  • 96. [Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice].
    Kushch AA; Galegov GA; Klimova RR; Kozlov AIu; Litvin AA
    Antibiot Khimioter; 2008; 53(7-8):31-4. PubMed ID: 19227121
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 98. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    De Clercq E; Holý A; Rosenberg I
    Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Newer compounds in therapy of herpes simplex keratitis.
    Hyndiuk RA; Kaufman HE
    Arch Ophthalmol; 1967 Nov; 78(5):600-5. PubMed ID: 4293002
    [No Abstract]   [Full Text] [Related]  

  • 100. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
    Lalezari JP; Drew WL; Glutzer E; Miner D; Safrin S; Owen WF; Davidson JM; Fisher PE; Jaffe HS
    J Infect Dis; 1994 Sep; 170(3):570-2. PubMed ID: 8077713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.